HopeStage
Back to all studies
CompletedEUCTR 2017-001946-93

Double-blind, placebo-controlled randomised study on the efficacy of naloxone nasal spray for the treatment of Addiction

This historical record does not confirm current site availability.

Historical research recordFinland
The study in practice

Understand this study

What did researchers investigate?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations
Finland
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateNot clearly listed
Recruitment status
Completed
Enrollment listed in the registry
Not clearly listed
Sponsor
National Instute of Health and Welfare
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Finland
Age range
Not clearly listed
Official registry ID
EUCTR 2017-001946-93
Official title
Show the full official title

Double-blind, placebo-controlled randomised study on the efficacy of naloxone nasal spray for the treatment of gambling disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Finland

Registry details
Historical country statuses

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Instute of Health and Welfare.

Want to explore more studies?

Explore studies